Papua New Guinea vs Saint Helena: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Papua New Guinea
2.5%
in 2024
Saint Helena
2.0%
in 2024
Papua New Guinea rank
11th
Saint Helena rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Papua New Guinea
- Saint Helena
How they compare
Papua New Guinea currently reports 2.5% against 2.0% in Saint Helena, a difference of 0.5%.
That makes Papua New Guinea's figure about 1.2 times Saint Helena's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Saint Helena ahead.
Papua New Guinea ranks 11th and Saint Helena ranks 14th of 246 countries.
Across the 2 decades both report, Papua New Guinea averaged higher in 1 and Saint Helena in 1.
Head to head by decade
| Decade | Papua New Guinea | Saint Helena | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 2.7% | 0.8% | Saint Helena |
| 2020s | 2.4% | 2.3% | 0.1% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Papua New Guinea or Saint Helena?
- Papua New Guinea, at 2.5% against 2.0% in Saint Helena as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Papua New Guinea and Saint Helena?
- 0.5%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Saint Helena?
- 10 years are reported by both, from 2015 to 2024.
- How do Papua New Guinea and Saint Helena rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Papua New Guinea ranks 11th and Saint Helena ranks 14th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.